Attached files
| file | filename |
|---|---|
| EX-99.1 - Inotiv, Inc. | v206348_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 22, 2010
BIOANALYTICAL
SYSTEMS, INC.
(Exact
name of registrant as specified in its charter)
|
Indiana
|
0-23357
|
35-1345024
|
||
|
(State or other
jurisdiction of
incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification
No.)
|
|
2701 KENT AVENUE
WEST LAFAYETTE, INDIANA
|
47906-1382
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (765) 463-4527
The
information provided in Item 2.02 and Item 9.01 of this Form 8-K is being
furnished and shall not be deemed "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that Section. The information in Item 2.02 and Item 9.01 of this
Form 8-K shall not be incorporated by reference into any registration statement
or other document pursuant to the Securities Act of 1933, as
amended.
Item
2.02. Results of Operations and Financial
Condition.
On
December 22, 2010, Bioanalytical Systems, Inc. issued a press release announcing
results for the three and twelve months of fiscal 2010, ending September 30,
2010. The full text of the press release is furnished as Exhibit 99.1 to this
Form 8-K and is incorporated herein by reference.
Item
9.01. Financial Statements and
Exhibits.
(a)
Not applicable.
(b)
Not applicable.
(c)
Not applicable.
(d)
Exhibits
99.1
Bioanalytical Systems, Inc. press release, issued December 22,
2010.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Bioanalytical
Systems, Inc.
|
||
|
Date:
December 22, 2010
|
By:
|
/s/ Michael
R. Cox
|
|
Michael
R. Cox
|
||
|
Vice
President, Finance and Administration, Chief
Financial
Officer and
Treasurer
|
||
Exhibit
Index
|
Exhibit No.
|
Description
|
|
|
99.1
|
Bioanalytical
Systems, Inc. press release, issued December 22,
2010.
|